首页> 外国专利> NEW POLYPEPTIDE, ITS PRODUCTION, DNA CAPABLE OF CODING THE SAME POLYPEPTIDE, VECTOR COMPOSED OF THE SAME DNA, HOST CELL TRANSFORMED BY THE SAME VECTOR, ANTIBODY AGAINST THE SAME POLYPEPTIDE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME POLYPEPTIDE OR ANTIBODY

NEW POLYPEPTIDE, ITS PRODUCTION, DNA CAPABLE OF CODING THE SAME POLYPEPTIDE, VECTOR COMPOSED OF THE SAME DNA, HOST CELL TRANSFORMED BY THE SAME VECTOR, ANTIBODY AGAINST THE SAME POLYPEPTIDE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME POLYPEPTIDE OR ANTIBODY

机译:新多肽,其生产,能够编码相同多肽的DNA,由相同DNA组成的矢量,由相同矢量转化的细胞,针对相同多肽的抗体和包含相同多肽或抗体的药物组合物

摘要

PURPOSE:To obtain a new polypeptide, comprising a specific amino acid sequence, having biological activities concerned in survival and proliferation of a hematopoietic stem cell and useful for preventing and treating inflammatory diseases, deficiency in the hematopoietic stem cell after the bone marrow transplantation, leukemia, etc. CONSTITUTION:This polypeptide is composed of an amino acid sequence expressed by sequence table I which is in a substantially pure form, its homolog, its fragment or a homolog of the fragment. Furthermore, the polypeptide is obtained by culturing a host cell transformed by an expression vector composed of a DNA capable of coding the polypeptide under conditions for expressing the polypeptide.
机译:目的:获得一种具有特定氨基酸序列的新多肽,该多肽具有与造血干细胞的存活和增殖有关的生物学活性,可用于预防和治疗炎症性疾病,骨髓移植后造血干细胞缺乏,白血病组成:该多肽由序列表I所表达的氨基酸序列组成,该序列基本上为纯形式,其同源物,其片段或该片段的同源物。此外,通过在表达所述多肽的条件下培养由表达载体转化的宿主细胞,所述宿主细胞被表达载体转化,所述表达载体由能够编码所述多肽的DNA组成。

著录项

  • 公开/公告号JPH07188294A

    专利类型

  • 公开/公告日1995-07-25

    原文格式PDF

  • 申请/专利权人 ONO PHARMACEUT CO LTD;

    申请/专利号JP19940272889

  • 申请日1994-10-12

  • 分类号C07K14/52;A61K38/00;A61K39/395;C07H21/04;C07K16/24;C12N5/10;C12N15/09;C12P21/02;C12P21/08;

  • 国家 JP

  • 入库时间 2022-08-22 04:25:34

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号